USP’s Diane McCarthy on the emerging standards platform and opportunities for stakeholders to help shape standards evolution.
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results